NCT03030378 2026-03-19Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid TumorsNational Cancer Institute (NCI)Phase 1 Active not recruiting36 enrolled
NCT02483312 2025-12-01A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)University Health Network, TorontoPhase 1 Active not recruiting9 enrolled